The Sprott Foundation donates $25 million to UHN's Department of Surgery
On June 4, Dr. Bob Bell, President and CEO of UHN and Dr. Shaf Keshavjee, Surgeon-in-Chief of UHN, announced a $25-million transformational gift from The Sprott Foundation in support of the Department of Surgery. This represents the largest private contribution to a Department of Surgery in Canada, and one of the largest in UHN's history.
The Sprott Foundation's funding established The Sprott Department of Surgery at UHN and will support the recruitment and retention of the world's best surgeons and crucial investments in leading-edge surgical technology – including advanced robotics, image-guided therapeutics and the latest in organ repair and regeneration technology.
"June 4 marks a pivotal day in surgical care, not only at UHN, but in operating rooms around the world," said Dr. Keshavjee. "The Sprott Department of Surgery will provide the best surgical care in a state-of-the-art and compassionate environment, while advancing the latest procedures that will transform people's lives."
The Department of Surgery at UHN encompasses the surgical programs of Toronto General, Toronto Western and Princess Margaret Hospitals and is the country's biggest, performing 25,000 procedures annually. As a provincial and national referral centre, UHN's surgeons perform the most complex procedures in the country, with the lowest mortality rates in Canada.
"We support organizations that are leaders in their field," said Eric Sprott, founder of The Sprott Foundation and Sprott Asset Management. "Surgeons at UHN helped discover insulin as a treatment for diabetes and performed the world's first successful single- and double-lung transplants. These innovations have saved millions of lives around the world, and we are proud to partner with UHN to fuel the next world-changing discovery."
A portion of The Sprott Foundation investment will support the creation of a Transplant Organ Repair and Regeneration Centre (TORRC), designed to help address the shortage of suitable donor organs in Ontario. The Centre will build on the success of the Toronto XVIVO Lung Perfusion System developed by Dr. Keshavjee that assesses, treats and repairs injured donor lungs outside the body using gene therapy, prior to transplantation – a personalized approach to donor organ management.